NASDAQ:FPRX - Five Prime Therapeutics Price Target & Analyst Ratings

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

7 Wall Street analysts have issued ratings and price targets for Five Prime Therapeutics in the last 12 months. Their average twelve-month price target is $21.3333, suggesting that the stock has a possible upside of 287.88%. The high price target for FPRX is $44.00 and the low price target for FPRX is $10.00. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."

Five Prime Therapeutics (NASDAQ:FPRX) Consensus Price Target History

Five Prime Therapeutics (NASDAQ:FPRX) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
6/3/2019	Wells Fargo & Co	Downgrade	Outperform ➝ Market Perform	$35.00 ➝ $10.00	High
5/29/2019	Roth Capital	Initiated Coverage	Neutral ➝ Neutral	$10.00 ➝ $10.00	Medium
4/12/2019	Guggenheim	Initiated Coverage	Buy	$24.00	High
2/27/2019	Cowen	Reiterated Rating	Buy		High
1/17/2019	Wedbush	Upgrade	Neutral ➝ Outperform	$16.00	High
9/13/2018	Leerink Swann	Initiated Coverage	Outperform ➝ Outperform	$24.00	High
8/20/2018	Citigroup	Lower Price Target	Buy ➝ Buy	$60.00 ➝ $44.00	Low
6/28/2018	Raymond James	Initiated Coverage	Market Perform		High
6/15/2018	JPMorgan Chase & Co.	Initiated Coverage	Neutral	$19.00	High
5/10/2018	Goldman Sachs Group	Initiated Coverage	Neutral	$20.00	Medium
2/28/2018	BMO Capital Markets	Lower Price Target	Outperform ➝ Outperform	$75.00 ➝ $60.00	Low
2/28/2018	Nomura	Lower Price Target	Buy ➝ Buy	$94.00 ➝ $25.00	High
11/6/2017	Royal Bank of Canada	Boost Price Target	Outperform ➝ Outperform	$41.00 ➝ $50.00	N/A
9/12/2017	Jefferies Financial Group	Reiterated Rating	Buy	$52.00	High

(Data available from 7/23/2017 forward)